Security key
641288105
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)
CUSIP: 641288105
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 23,932,784
- Total 13F value
- $294,127,661
- Share change
- +2,942,019
- Put/Call ratio
- 17%
- SEC-reported price per share
- $12.29
- Number of holders
- 89
- Value change
- +$42,108,506
- Number of buys
- 60
- Number of sells
- 20
- Shares outstanding
- 34,207,386
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
89
Top holders
10
NPCE full security history
Ownership snapshot
Full 13F holder table
NeuroPace Inc SEC filings
NeuroPace Inc company facts
Broader feeds
Ownership snapshot
Top reported holders of NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Polar Capital Holdings Plc
Disclosed value leader
KCK LTD.
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 9.1%
13D/G row: Polar Capital Holdings Plc
Showing 1-6 of 15 holder rows.
Quick read
Polar Capital Holdings Plc leads the comparable SEC ownership view at 9.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Polar Capital Holdings Plc's linked filing trail.
Comparable ownership
Top 5
Polar Capital Holdings Plc
9.1%
MORGAN STANLEY
8.3%
Kent Lake PR LLC
4.9%
KCK LTD.
15%
ORBIMED ADVISORS LLC
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc |
13D/G
|
9.1%
|
$34,534,675
2,972,003 shares
|
$0 | 31 Mar 2025 |
| MORGAN STANLEY |
13D/G
13F
Company
|
8.3%
|
$28,926,723
2,489,391 shares
|
$0 | 31 Dec 2024 |
| Kent Lake PR LLC |
13D/G
13F
Company
|
4.9%
|
$17,227,289
1,482,555 shares
|
+$116,944 | 31 Dec 2024 |
| KCK LTD. |
13F
Company
|
15%
|
$58,980,756
5,270,845 shares
|
— | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
10%
|
$38,116,889
3,406,335 shares
|
— | 31 Dec 2024 |
| Soleus Capital Management, L.P. |
13F
Company
|
7.1%
|
$27,227,150
2,433,168 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
89
Shares
23,932,784
Rows available
89
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
89
Q1 2025 holders
89
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|